Modulation of Glucagon Receptor Pharmacology by Receptor Activity-modifying Protein-2 (RAMP2)
出版年份 2015 全文链接
标题
Modulation of Glucagon Receptor Pharmacology by Receptor Activity-modifying Protein-2 (RAMP2)
作者
关键词
-
出版物
JOURNAL OF BIOLOGICAL CHEMISTRY
Volume 290, Issue 38, Pages 23009-23022
出版商
American Society for Biochemistry & Molecular Biology (ASBMB)
发表日期
2015-07-22
DOI
10.1074/jbc.m114.624601
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Structural Basis for Receptor Activity-Modifying Protein-Dependent Selective Peptide Recognition by a G Protein-Coupled Receptor
- (2015) Jason M. Booe et al. MOLECULAR CELL
- Cardiomyocyte glucagon receptor signaling modulates outcomes in mice with experimental myocardial infarction
- (2015) Safina Ali et al. Molecular Metabolism
- Investigating G protein signalling bias at the glucagon-like peptide-1 receptor in yeast
- (2014) C Weston et al. BRITISH JOURNAL OF PHARMACOLOGY
- Loss of constitutive activity is correlated with increased thermostability of the human adenosine A2Areceptor
- (2013) Nicolas Bertheleme et al. BRITISH JOURNAL OF PHARMACOLOGY
- Receptor activity-modifying protein-dependent effects of mutations in the calcitonin receptor-like receptor: implications for adrenomedullin and calcitonin gene-related peptide pharmacology
- (2013) H A Watkins et al. BRITISH JOURNAL OF PHARMACOLOGY
- A Physiologically Required G Protein-coupled Receptor (GPCR)-Regulator of G Protein Signaling (RGS) Interaction That Compartmentalizes RGS Activity
- (2013) Wayne Croft et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Structure of the human glucagon class B G-protein-coupled receptor
- (2013) Fai Yiu Siu et al. NATURE
- Insights into the structure of class B GPCRs
- (2013) Kaspar Hollenstein et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Quantitative analysis of human ras localization and function in the fission yeastSchizosaccharomyces pombe
- (2013) Michael Bond et al. YEAST
- Receptor activity modifying proteins (RAMPs) interact with the VPAC2receptor and CRF1receptors and modulate their function
- (2012) D Wootten et al. BRITISH JOURNAL OF PHARMACOLOGY
- A network meta-analysis to compare glycaemic control in patients with type 2 diabetes treated with exenatide once weekly or liraglutide once daily in comparison with insulin glargine, exenatide twice daily or placebo
- (2012) D. A. Scott et al. DIABETES OBESITY & METABOLISM
- Structure and dynamics of the M3 muscarinic acetylcholine receptor
- (2012) Andrew C. Kruse et al. NATURE
- Targeting the glucagon receptor family for diabetes and obesity therapy
- (2012) Young Min Cho et al. PHARMACOLOGY & THERAPEUTICS
- Molecular basis for negative regulation of the glucagon receptor
- (2012) C. M. Koth et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- GPCR activation: a mutagenic spotlight on crystal structures
- (2012) Edward C. Hulme TRENDS IN PHARMACOLOGICAL SCIENCES
- Glucagon antagonism as a potential therapeutic target in type 2 diabetes
- (2011) J. I. Bagger et al. DIABETES OBESITY & METABOLISM
- A survey of small molecule glucagon receptor antagonists from recent patents (2006 – 2010)
- (2011) Dong-Ming Shen et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Pharmacology of GPR55 in Yeast and Identification of GSK494581A as a Mixed-Activity Glycine Transporter Subtype 1 Inhibitor and GPR55 Agonist
- (2011) A. J. Brown et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Residues within the Transmembrane Domain of the Glucagon-Like Peptide-1 Receptor Involved in Ligand Binding and Receptor Activation: Modelling the Ligand-Bound Receptor
- (2011) K. Coopman et al. MOLECULAR ENDOCRINOLOGY
- Comparative Effects of the Endogenous Agonist Glucagon-Like Peptide-1 (GLP-1)-(7-36) Amide and the Small-Molecule Ago-Allosteric Agent "Compound 2" at the GLP-1 Receptor
- (2010) K. Coopman et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- The metabolic actions of glucagon revisited
- (2010) Kirk M. Habegger et al. Nature Reviews Endocrinology
- Seven Transmembrane Receptors as Shapeshifting Proteins: The Impact of Allosteric Modulation and Functional Selectivity on New Drug Discovery
- (2010) T. Kenakin et al. PHARMACOLOGICAL REVIEWS
- Crystal Structure of Glucagon-like Peptide-1 in Complex with the Extracellular Domain of the Glucagon-like Peptide-1 Receptor
- (2009) Christina Rye Underwood et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Determination of Adenosine A1 Receptor Agonist and Antagonist Pharmacology Using Saccharomyces cerevisiae: Implications for Ligand Screening and Functional Selectivity
- (2009) G. D. Stewart et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Glucagon receptor mediates calcium signaling by coupling to Gαq/11and Gαi/oin HEK293 cells
- (2009) Yazhen Xu et al. JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION
- Islet G protein-coupled receptors as potential targets for treatment of type 2 diabetes
- (2009) Bo Ahrén NATURE REVIEWS DRUG DISCOVERY
- Cardioprotective and Vasodilatory Actions of Glucagon-Like Peptide 1 Receptor Are Mediated Through Both Glucagon-Like Peptide 1 Receptor–Dependent and –Independent Pathways
- (2008) Kiwon Ban et al. CIRCULATION
- Receptor Activity-Modifying Proteins Differentially Modulate the G Protein-Coupling Efficiency of Amylin Receptors
- (2008) Maria Morfis et al. ENDOCRINOLOGY
- Physiology of the pancreatic α-cell and glucagon secretion: role in glucose homeostasis and diabetes
- (2008) Ivan Quesada et al. JOURNAL OF ENDOCRINOLOGY
- Protective effects of GLP-1 analogues exendin-4 and GLP-1(9–36) amide against ischemia–reperfusion injury in rat heart
- (2007) David P. Sonne et al. REGULATORY PEPTIDES
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More